-+ 0.00%
-+ 0.00%
-+ 0.00%

JOURNEY MEDICAL CORPORATION ANNOUNCES PUBLICATION OF CLINICAL TRIAL RESULTS ASSESSING THE IMPACT OF EMROSI™ (DFD-29) ON MICROBIAL FLORA OF HEALTHY ADULTS IN THE JOURNAL OF DRUGS IN DERMATOLOGY

Reuters·12/10/2025 13:30:01

Please log in to view news